AMARIN CORP PLC\UK Other Receivables, Net, Current
AMARIN CORP PLC\UK (AMRN) had Other Receivables, Net, Current of $25.65 million as of 2018-09-30, per its 10-Q filed 2018-11-01.
Discontinued › Notes
us-gaap:OtherReceivablesNetCurrent · last filed 2018-11-01
- 2018-09-30: Other Receivables, Net, Current $25.65M.
- 2010-12-31: Other Receivables, Net, Current $351.00K.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2018-09-30 | $25.65M 10-Q · filed 2018-11-01 |
| 2010-12-31 | $351.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |